Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
4924 On Other Exchanges
Symbol
Exchange
4924 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

dr ci:labo co ltd (4924) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for DR CI:LABO CO LTD (4924)

Related News

No related news articles were found.

dr ci:labo co ltd (4924) Related Businessweek News

No Related Businessweek News Found

dr ci:labo co ltd (4924) Details

Dr. Ci:Labo Co., Ltd. develops, manufactures, and sells cosmetics, health foods, and beauty and other products. The company offers various skin care cosmetics, including low-stimulant cosmetics and anti-aging products for people of various ages; and supplements and food products. It sells its products under the Dr.Ci:Labo, Labo Labo, and Genomer brand names through mail order, as well as through wholesale channels to drug stores, pharmacies, variety stores, cosmetics specialty stores, and GMS; and operates Dr. Ci:Labo corners in directly managed stores, department stores, and shopping centers. The company operates in Japan, Taiwan, Hong Kong, Singapore, Malaysia, and South Korea; and Hawaii, the United States. Dr. Ci:Labo Co., Ltd. was founded in 1999 and is headquartered in Tokyo, Japan.

704 Employees
Last Reported Date: 10/23/14
Founded in 1999

dr ci:labo co ltd (4924) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

dr ci:labo co ltd (4924) Key Developments

Dr. Ci:Labo Co., Ltd. to Report Q3, 2015 Results on Jun 10, 2015

Dr. Ci:Labo Co., Ltd. announced that they will report Q3, 2015 results on Jun 10, 2015

Dr. Ci:Labo Co., Ltd. Reports Consolidated Earnings Results for the Six Months Ended January 31, 2015; Provides Dividend Guidance for the Year Ending July 31, 2015; Provides Earnings Guidance for the Fiscal Year Ending July 31, 2015

Dr. Ci:Labo Co., Ltd. reported consolidated earnings results for the six months ended January 31, 2015. For the quarter, the company reported operating income of ¥2,917 million, ordinary income of ¥2,992 million, net income of ¥1,916 million or ¥76.98 per share on net sales of ¥17,757 million against operating income of ¥3,689 million, ordinary income of ¥3,721 million, net income of ¥2,287 million or ¥91.77 per share on net sales of ¥16,744 million for the same period a year ago. Net income before taxes was ¥2,991,754,000 against ¥3,717,781,000 a year ago. Net cash provided by operating activities was ¥1,635,845,000 against ¥2,987,436,000 a year ago. Acquisition of tangible fixed assets was ¥25,498,000 against ¥251,912,000 a year ago. Acquisition of intangible fixed assets was ¥62,442,000 against ¥30,939,000 a year ago. The company provides dividend guidance for the year ending July 31, 2015. The company expects a dividend of ¥82.00 per share against ¥81.00 per share for the same period a year ago. For the fiscal year ending July 31, 2015, the company expects operating income of ¥8,500 million, ordinary income of ¥8,500 million, net income of ¥5,400 million or ¥217.08 per share on net sales of ¥39,300 million.

Dr. Ci:Labo Co., Ltd., Q2 2015 Earnings Call, Mar 13, 2015

Dr. Ci:Labo Co., Ltd., Q2 2015 Earnings Call, Mar 13, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4924:JP ¥2,393.00 JPY +44.00

4924 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4924.
View Industry Companies
 

Industry Analysis

4924

Industry Average

Valuation 4924 Industry Range
Price/Earnings 29.6x
Price/Sales 3.1x
Price/Book 4.9x
Price/Cash Flow 30.2x
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DR CI:LABO CO LTD, please visit www.ci-labo.com/ir/e/index.html. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.